Xeno Transplants (XENO) Stock Statistics & Valuation Metrics

Xeno Transplants has a market cap or net worth of $4.04K. The enterprise value is ―.

Xeno Transplants has 40,364,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Xeno Transplants’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Xeno Transplants is ―. Xeno Transplants’s PEG ratio is ―.

In the last 12 months, Xeno Transplants had revenue of ― and earned -128.19K in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Xeno Transplants pays an annual dividend of ―, resulting in a dividend yield of ―

Xeno Transplants upcoming earnings date is ―, ―.

Xeno Transplants as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Xeno Transplants has paid ― in taxes.

Xeno Transplants EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Xeno Transplants has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Xeno Transplants is ―, which is 11.43% higher than the current price. The consensus rating is ―